Please login to the form below
Pfizer still number one - just
The industry’s upper ranks are revealed in the latest PMLiVE Top Pharma List figures
No price ceiling for rare disease drugs, say MPs
BIA survey comes ahead of consultation on evaluation framework for ultra-orphans
Alderley Park 'will remain flagship bioscience location'
Manchester Science Parks takes over former AstraZeneca site
FDA approves migraine headband
STX-Med’s electronic Cefaly device offers drug-free treatment option
Trial boost for Novo's IDegLira ambitions
Company says drug shows weight benefits and low risk of hypoglycaemia
Publicis builds North American portfolio
Latest acquisition is digital marketing services agency Hawkeye
AZ launches combination diabetes drug in UK
Xigduo combines Forxiga and metformin
J&J adds Manchester to partnering network
Adds satellite office for London innovation hub
GSK raises stake in Indian subsidiary
Company eyes long-term growth of market
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
-
Use data responsiblyIt’s imperative that opening up clinical trial data doesn’t compromise patient safety
-
Pharma’s four options for innovationOnly genuinely creative companies will profit from the future
-
Pharma payments to US doctors downFollows intensified public scrutiny and introduction of the Sunshine Act
-
Draftfcb Healthcare rebrands and acquires HaleswayThe US agency will operate as FCB Health
-
FDA scrutiny of alirocumab hits Regeneron and SanofiRegulator to assess neurocognitive effects of cholesterol drug
-
EMA to restrict use of domperidone and diacereinRegulator's pharmacovigilance advisors also want insomnia drug zolpidem's labelling tightened up
-
New data puts Jakafi on course for blockbuster statusNovartis/Incyte drug meets targets in blood cancer trial
-
Pfizer recalls depression drug in USWrong medicine found in bottle of Effexor XR
-
J&J gets EU green light for novel TB drugSirturo approved to treat multidrug resistant form of the disease
Latest appointments
-
Owen Mumford appoints Judith CharlesShe joins medial device company as sales and marketing director
-
Isgro boosts senior teamBettina Weber joins German communications agency
-
Roche appoints new oncology research headWilliam Pao leaves academia for pharma role
-
Oxford Pharmascience adds to boardJohn Goddard is former head of group strategic planning and business at AstraZeneca
-
Stallergenes appoints Christian Chavy CEOHe will replace Roberto Gradnik at the end of this month
Featured jobs
- Account Director- Healthcare
- Highly Competitive Salary
- Client Director, Healthcare, Dublin
- Competitive salary, plus benefits
- Account Director
- up to 60k
- Account Director – PR Healthcare
- Excellent salary and package
- Account Director - Medical Education
- Competitive + excellent benefits
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Account Associate
- On application
- Account Manager / (Senior) Analyst – Market Access
- Up to £45,000 plus bonus
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Business Development Director
- Competitive Salary Offered
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
Subscribe to our email news alerts
PMHub
Gem Marketing Ltd
GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....
Latest intelligence
- NICE and ‘ultra orphans’
- NICE and its processes for ‘highly specialised therapies’...
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
Quick links
